LODINE XL Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Lodine Xl, and when can generic versions of Lodine Xl launch?

Lodine Xl is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in LODINE XL is etodolac. There are twenty-three drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the etodolac profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lodine Xl

A generic version of LODINE XL was approved as etodolac by SANDOZ on April 11^th, 1997.

Try a Trial

Summary for LODINE XL

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	118
Patent Applications:	4,510
Formulation / Manufacturing:	see details
DailyMed Link:	LODINE XL at DailyMed

Drug patent expirations by year for LODINE XL

Anatomical Therapeutic Chemical (ATC) Classes for LODINE XL

M01AB	Acetic acid derivatives and related substances
M01A	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M	Musculo-skeletal system

US Patents and Regulatory Information for LODINE XL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Pharms Inc	LODINE XL	etodolac	TABLET, EXTENDED RELEASE;ORAL	020584-001	Oct 25, 1996		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Wyeth Pharms Inc	LODINE XL	etodolac	TABLET, EXTENDED RELEASE;ORAL	020584-003	Jan 20, 1998		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Wyeth Pharms Inc	LODINE XL	etodolac	TABLET, EXTENDED RELEASE;ORAL	020584-002	Oct 25, 1996		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for LODINE XL

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Pharms Inc	LODINE XL	etodolac	TABLET, EXTENDED RELEASE;ORAL	020584-002	Oct 25, 1996	⤷ Try a Trial	⤷ Try a Trial
Wyeth Pharms Inc	LODINE XL	etodolac	TABLET, EXTENDED RELEASE;ORAL	020584-001	Oct 25, 1996	⤷ Try a Trial	⤷ Try a Trial
Wyeth Pharms Inc	LODINE XL	etodolac	TABLET, EXTENDED RELEASE;ORAL	020584-003	Jan 20, 1998	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for LODINE XL

See the table below for patents covering LODINE XL around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Greece	3001739		⤷ Try a Trial
Finland	884245		⤷ Try a Trial
Singapore	27194		⤷ Try a Trial
Japan	H02270820	SLOWLY RELEASABLE ETHODRUG	⤷ Try a Trial
Israel	87757		⤷ Try a Trial
Australia	2215388		⤷ Try a Trial
Bulgaria	60697		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for LODINE XL

Anatomical Therapeutic Chemical (ATC) Classes for LODINE XL

Make Better Decisions: Try a trial or see plans & pricing